NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial.
Saved in:
| Title: | NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial. |
|---|---|
| Authors: | Fan, Zhiguo1 (AUTHOR), Li, Duocai1 (AUTHOR), Yan, Shi2 (AUTHOR), Zhao, Xianzhi3,4 (AUTHOR), Yin, Lei1 (AUTHOR), Xu, Weidong1 (AUTHOR), Wang, Ye1 (AUTHOR), Zhang, Huojun3 (AUTHOR) huojunzh@163.com, Chang, Yifan5 (AUTHOR) 13661652533@163.com, Ren, Shancheng1 (AUTHOR) renshancheng@gmail.com |
| Source: | BMC Cancer. 4/24/2025, Vol. 25 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-024-13201-w |
